Molecule intelOpportunity: Lower0

Biotin

53 brands · 32 companies · product forms

Opportunity snapshot

Launch attractiveness
28
Market saturation
80
Price room
100
Regulatory risk
0
53
brands
32
companies
Rs 536.77
median price
15
price points
221.93x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 8%

Price room

Across observed sources and strengths
CheapestRs 45.3
MedianRs 536.77
Most expensiveRs 10,053.24
Spread221.93×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 221.93x across 15 trusted points (Rs 45.3-10053.24). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Why this score

Launch attractiveness

40% supply-gap(0) + 25% price-variation(100) + 20% low-competition(20) + 15% supply-disruption(0), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

32 canonical companies and 53 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 221.93x across 15 trusted points (Rs 45.3-10053.24). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

No DRAP alerts on this molecule's brands.

Confidence

Reduced by: no ATC code.

Packaged brief for this lower opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.